2023 Q4 Form 10-Q Financial Statement

#000121390023084764 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $5.191M $4.508M $1.976M
YoY Change 102.77% 128.14% 32.88%
Cost Of Revenue $1.100M $661.0K $258.0K
YoY Change 71.88% 156.2% -27.33%
Gross Profit $4.091M $3.847M $1.718M
YoY Change 113.07% 123.92% 51.76%
Gross Profit Margin 78.81% 85.34% 86.94%
Selling, General & Admin $6.941M $6.724M $5.657M
YoY Change 11.79% 18.86% 21.74%
% of Gross Profit 169.67% 174.79% 329.28%
Research & Development $1.108M $1.249M $1.617M
YoY Change -31.94% -22.76% 243.84%
% of Gross Profit 27.08% 32.47% 94.12%
Depreciation & Amortization $227.0K $300.0K $153.0K
YoY Change 53.38% 96.08% 60.87%
% of Gross Profit 5.55% 7.8% 8.91%
Operating Expenses $8.049M $7.973M $7.274M
YoY Change 2.71% 9.61% 42.15%
Operating Profit -$3.958M -$4.126M -$5.556M
YoY Change -33.11% -25.74% 39.42%
Interest Expense $135.0K $90.00K $103.0K
YoY Change -4.93% -12.62% 2589.3%
% of Operating Profit
Other Income/Expense, Net -$184.0K $94.00K $103.0K
YoY Change 18300.0% -8.74% 163392.06%
Pretax Income -$4.007M -$4.032M -$5.453M
YoY Change -30.63% -26.06% 36.84%
Income Tax $25.00K
% Of Pretax Income
Net Earnings -$4.032M -$4.032M -$5.453M
YoY Change -30.36% -26.06% 36.54%
Net Earnings / Revenue -77.67% -89.44% -275.96%
Basic Earnings Per Share -$0.68 -$0.08
Diluted Earnings Per Share -$0.61 -$0.68 -$76.71K
COMMON SHARES
Basic Shares Outstanding 6.002M shares 5.985M shares 71.12M shares
Diluted Shares Outstanding 5.945M shares 4.544M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.33M $13.50M $21.65M
YoY Change -41.67% -37.63% -44.49%
Cash & Equivalents $10.33M $13.46M $21.65M
Short-Term Investments
Other Short-Term Assets $1.086M $1.300M $1.325M
YoY Change 0.74% -1.89% -10.25%
Inventory $2.160M $2.495M $1.974M
Prepaid Expenses
Receivables $717.0K $589.0K $364.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.29M $17.84M $25.31M
YoY Change -32.49% -29.51% -39.58%
LONG-TERM ASSETS
Property, Plant & Equipment $204.0K $178.0K $77.00K
YoY Change 308.0% 131.17% -54.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $495.0K $760.0K $853.0K
YoY Change -36.05% -10.9% -82.86%
Total Long-Term Assets $1.808M $2.269M $4.183M
YoY Change -49.54% -45.76% -26.44%
TOTAL ASSETS
Total Short-Term Assets $14.29M $17.84M $25.31M
Total Long-Term Assets $1.808M $2.269M $4.183M
Total Assets $16.10M $20.11M $29.49M
YoY Change -34.96% -31.82% -38.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.163M $3.033M $1.901M
YoY Change 1.6% 59.55% 52.02%
Accrued Expenses $5.871M $5.390M $4.670M
YoY Change 21.25% 15.42% 5.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.123M $8.508M $6.642M
YoY Change 15.3% 28.09% 15.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $537.0K $600.0K $645.0K
YoY Change -14.08% -6.98% -9.86%
Total Long-Term Liabilities $537.0K $600.0K $645.0K
YoY Change -14.08% -6.98% -9.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.123M $8.508M $6.642M
Total Long-Term Liabilities $537.0K $600.0K $645.0K
Total Liabilities $8.660M $9.068M $7.287M
YoY Change 12.91% 24.44% 12.9%
SHAREHOLDERS EQUITY
Retained Earnings -$165.2M -$161.2M -$140.6M
YoY Change 12.87% 14.65% 17.88%
Common Stock $172.7M $172.3M $162.9M
YoY Change 5.62% 5.79% 1.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.442M $11.04M $22.20M
YoY Change
Total Liabilities & Shareholders Equity $16.10M $20.11M $29.49M
YoY Change -34.96% -31.82% -38.01%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$4.032M -$4.032M -$5.453M
YoY Change -30.36% -26.06% 36.54%
Depreciation, Depletion And Amortization $227.0K $300.0K $153.0K
YoY Change 53.38% 96.08% 60.87%
Cash From Operating Activities -$3.123M -$2.380M -$4.607M
YoY Change -22.2% -48.34% 33.63%
INVESTING ACTIVITIES
Capital Expenditures $41.00K $80.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$41.00K -$80.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.000K 7.490M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.123M -2.380M -4.607M
Cash From Investing Activities -41.00K -80.00K 0.000
Cash From Financing Activities -3.000K 7.490M 0.000
Net Change In Cash -3.164M 5.030M -4.607M
YoY Change -21.18% -209.18% -119.76%
FREE CASH FLOW
Cash From Operating Activities -$3.123M -$2.380M -$4.607M
Capital Expenditures $41.00K $80.00K
Free Cash Flow -$3.164M -$2.460M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 ecor Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
353000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4508000 usd
CY2023Q3 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
1058000 usd
CY2023Q3 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
1899000 usd
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001560258
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-15
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38538
dei Entity Registrant Name
EntityRegistrantName
electroCore, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3454976
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Forge Way
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 205
dei Entity Address City Or Town
EntityAddressCityOrTown
Rockaway
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07866
dei City Area Code
CityAreaCode
(973)
dei Local Phone Number
LocalPhoneNumber
290-0097
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ECOR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6002420 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13460000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17712000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
250000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
250000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
589000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
401000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2495000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1982000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1045000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
828000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
17839000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21173000 usd
CY2023Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
813000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2194000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
178000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
518000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
565000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
760000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
774000 usd
CY2023Q3 us-gaap Assets
Assets
20108000 usd
CY2022Q4 us-gaap Assets
Assets
24756000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3033000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2129000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5390000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4842000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
74000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8508000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7045000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
560000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
625000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
9068000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7670000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2023Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2023Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
71173 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
71173 shares
CY2022Q4 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
0.001
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5998836 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5998836 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4744886 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4744886 shares
CY2023Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
6000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
172304000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
163520000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-161172000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146370000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-98000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-69000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
11040000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17086000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20108000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24756000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4508000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1976000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10839000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6032000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
258000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1704000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
976000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
3847000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1718000 usd
us-gaap Gross Profit
GrossProfit
9135000 usd
us-gaap Gross Profit
GrossProfit
5056000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1249000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1617000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4213000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3892000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6724000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5657000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20233000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18121000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7973000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
7274000 usd
us-gaap Operating Expenses
OperatingExpenses
24446000 usd
us-gaap Operating Expenses
OperatingExpenses
22013000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4126000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5556000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15311000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-16957000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
94000 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
103000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
298000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
145000 usd
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
94000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
103000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
298000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
140000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4032000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5453000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15013000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16817000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-211000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-445000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4032000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5453000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14802000 usd
us-gaap Net Income Loss
NetIncomeLoss
-16372000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.2
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.45
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5945000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5945000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4544000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4544000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5149000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4746000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4746000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4032000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5453000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14802000 usd
us-gaap Net Income Loss
NetIncomeLoss
-16372000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-22000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-82000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-29000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-167000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-82000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-167000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4054000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5535000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14831000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16539000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17086000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5867000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
572000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11847000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4903000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-63000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
183000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7064000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22000 usd
CY2023Q3 ecor Stock And Warrants Issued During Period Value
StockAndWarrantsIssuedDuringPeriodValue
8144000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17962000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34689000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
657000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
11040000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
36648000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5582000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
777000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
31816000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5337000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-58000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
752000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
27173000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5453000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-82000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
566000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
22204000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14802000 usd
us-gaap Net Income Loss
NetIncomeLoss
-16372000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1298000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2095000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
735000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000 usd
ecor Net Noncash Lease Expense
NetNoncashLeaseExpense
46000 usd
ecor Net Noncash Lease Expense
NetNoncashLeaseExpense
34000 usd
us-gaap Inventory Write Down
InventoryWriteDown
258000 usd
us-gaap Inventory Write Down
InventoryWriteDown
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
54000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
241000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-74000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
72000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-58000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
219000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
22000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
904000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
963000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
549000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
184000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-55000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-45000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11545000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12631000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
165000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-165000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8144000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
657000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7487000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-29000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-163000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4252000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12794000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13710000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21895000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
211000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
445000 usd
us-gaap Interest Paid Net
InterestPaidNet
8000 usd
us-gaap Interest Paid Net
InterestPaidNet
6000 usd
ecor Insurance Premium Financing
InsurancePremiumFinancing
433000 usd
ecor Insurance Premium Financing
InsurancePremiumFinancing
522000 usd
CY2023Q3 ecor Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2 subsidiary
CY2023Q1 us-gaap Debt Instrument Convertible Stock Price Trigger
DebtInstrumentConvertibleStockPriceTrigger
1
CY2023Q1 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
10
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-15
us-gaap Use Of Estimates
UseOfEstimates
<div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div id="t_ft_Q9Y8OSSSWG00000000000000000000b"> <table cellpadding="0" cellspacing="0" style="height: 10px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr style="height: 10px;"> <td style="vertical-align: top; height: 10px; width: 3%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;"> (c) </span></p> </td> <td style="vertical-align: top; height: 10px; width: 97%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;"> Use of Estimates </span></p> </td> </tr> </tbody> </table> </div> </div> <p style="margin: 10pt 0pt 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2; text-align: justify; text-indent: 0pt;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit; margin: 6pt 0in 0in; text-align: justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include allowances for doubtful accounts, trade credits, rebates, co-payment assistance and sales returns, valuation of inventory, estimated useful life of licensed products and cloud computing arrangements, stock compensation, incremental borrowing rate and contingencies.   </span></span></p> </div> </div> </div>
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13460000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21645000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
250000 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
250000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
13710000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
21895000 usd
CY2023Q3 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
0 usd
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="margin: 0pt; text-indent: 0pt; line-height: 1.2;"> <table style="width: 100%; margin-left: 0.1px; border-collapse: collapse; font-family: 'times new roman'; font-size: 10pt;"> <tbody> <tr> <td style="width: 3%;"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: bold; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">(h)</span></td> <td style="width: 97%;"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: bold; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">Prior Year Presentation</span></td> </tr> </tbody> </table> </div> <p style="margin: 10pt 0pt 0pt; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0pt; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2; text-align: justify;"><span style="font-size: 10pt; line-height: inherit;"><span style="line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="font-family: 'Times New Roman', serif; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;">Prior year presentation has been conformed to current year presentation.</span></span></span></span></p>
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.602 pure
ecor Federal Supply Schedule Expire Date
FederalSupplyScheduleExpireDate
2024-01-15
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1976000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10839000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6032000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4508000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10839000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6032000 usd
ecor Payment Term For Customers
PaymentTermForCustomers
P30D
CY2022Q4 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
944000 usd
CY2022Q4 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
2879000 usd
CY2023Q3 ecor Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
351000 usd
CY2023Q3 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
3308000 usd
CY2022Q4 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
4176000 usd
CY2023Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
813000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2194000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2495000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1982000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
500000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
700000 usd
CY2023Q3 ecor Inventory Noncurrent Raw Materials
InventoryNoncurrentRawMaterials
0 usd
CY2022Q4 ecor Inventory Noncurrent Raw Materials
InventoryNoncurrentRawMaterials
100000 usd
CY2023Q3 ecor Inventory Noncurrent Work In Process
InventoryNoncurrentWorkInProcess
800000 usd
CY2022Q4 ecor Inventory Noncurrent Work In Process
InventoryNoncurrentWorkInProcess
2100000 usd
CY2023Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
38000000 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
114000000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
518000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
565000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
85000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
74000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
560000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
625000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
645000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
699000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y4M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2023Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.138 pure
CY2022Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.138 pure
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
41000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
168000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
171000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
161000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
157000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
216000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
914000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
269000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
645000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
715000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
524000 usd
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1873000 usd
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2042000 usd
CY2023Q3 ecor Accrued Legal Fees Litigation Expense Current
AccruedLegalFeesLitigationExpenseCurrent
1035000 usd
CY2022Q4 ecor Accrued Legal Fees Litigation Expense Current
AccruedLegalFeesLitigationExpenseCurrent
1001000 usd
CY2023Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
433000 usd
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
264000 usd
CY2023Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
573000 usd
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
534000 usd
CY2023Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
113000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
usd
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
224000 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
133000 usd
CY2023Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
180000 usd
CY2022Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
152000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
244000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
192000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5390000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4842000 usd
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-15
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1692 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
481 shares
CY2023Q1 us-gaap Proceeds From Operating Activities
ProceedsFromOperatingActivities
211000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
440000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
55.65
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
206000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
109000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
537000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
38.42
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
253000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
72.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
543000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
566000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1298000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2095000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2100000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.50 pure
ecor Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate Of Peer Entities
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRateOfPeerEntities
0.50 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.53
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.224 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.84 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2020Q3 ecor Number Of Investors As Defendants
NumberOfInvestorsAsDefendants
2 investors

Files In Submission

Name View Source Status
ecor-20230930_cal.xml Edgar Link unprocessable
0001213900-23-084764-index-headers.html Edgar Link pending
0001213900-23-084764-index.html Edgar Link pending
0001213900-23-084764.txt Edgar Link pending
0001213900-23-084764-xbrl.zip Edgar Link pending
ecor-20230930.htm Edgar Link pending
ecor-20230930.xsd Edgar Link pending
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex321_3.htm Edgar Link pending
ex322_4.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
ecor-20230930_def.xml Edgar Link unprocessable
ecor-20230930_lab.xml Edgar Link unprocessable
ecor-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ecor-20230930_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending